Pharmaceutical / Drug Definition :
Directly stimulates dopamine receptors in hypothalamus, causing release of prolactin-inhibitory factors and thereby relieving akinesia, rigidity, and tremors associated with Parkinson's disease. Also restores testicular or ovarian function and suppresses lactation.
FDA Label Requirements and Exceptions
Bromocriptine Mesylate
FDA Import Information
Bromocriptine Mesylate
FDA Detentions
Bromocriptine Mesylate (Bromocriptine Mesylate Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Bromocriptine Mesylate (Bromocriptine Mesylate Suppliers)
- Processors Bromocriptine Mesylate
- Repackers Bromocriptine Mesylate
- Relabelers Bromocriptine Mesylate
- Exporters Bromocriptine Mesylate
- Importers Bromocriptine Mesylate
For more information about Bromocriptine Mesylate, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
